Literature DB >> 20380332

Disparities in outpatient antidepressant prescribing patterns and determinants of resource utilization at a tertiary care cancer center.

Lincy S Lal1, Lesley-Ann N Miller, Rebecca Arbuckle, Frank Hung, Chun Feng, Andrea Adamus, Michael J Fisch.   

Abstract

Our objective was to assess the prevalence of use of different classes of antidepressants, prescribing patterns, and determinants of exposure to specific types of antidepressants and resource utilization at a comprehensive cancer center from 2001 to 2006. Data were collected from the institution's outpatient pharmacy database and cross-referenced with the institution's electronic medical record system. Data collected included demographic characteristics, cancer diagnosis, comorbidities, prescribing physician and service, type and number of antidepressant prescriptions, and resource utilization. Significant differences in the usage and prescribing patterns of the type of antidepressants were found in the analysis by gender and ethnicity, with women seeing a psychiatrist more often than men (P = 0.001) and Caucasians receiving more selective serotonin reuptake inhibitors (SSRIs) than other ethnic groups (P = 0.002). In terms of resource utilization, men had significantly more hospital admissions (P < 0.0001) and emergency room visits (P = 0.004) than women, whereas non-Caucasian ethnic groups had more emergency room visits (P < 0.0001) and clinic visits (P = 0.001) than Caucasians. Further investigation of men and non-Caucasians in the screening, evaluation, and treatment of depression is necessary to confirm disparities and evaluate their possible causes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20380332

Source DB:  PubMed          Journal:  J Support Oncol        ISSN: 1544-6794


  6 in total

1.  Use of and spending on supportive care medications among Medicare beneficiaries with cancer.

Authors:  Ilene H Zuckerman; Amy J Davidoff; Mujde Z Erten; Bruce Stuart; Thomas Shaffer; J Samantha Dougherty; Candice Yong
Journal:  Support Care Cancer       Date:  2014-08       Impact factor: 3.603

2.  Male-female patient differences in the association between end-of-life discussions and receipt of intensive care near death.

Authors:  Rashmi K Sharma; Holly G Prigerson; Frank J Penedo; Paul K Maciejewski
Journal:  Cancer       Date:  2015-05-14       Impact factor: 6.860

3.  ReCAP: Would Women With Breast Cancer Prefer to Receive an Antidepressant for Anxiety or Depression From Their Oncologist?

Authors:  Daniel C McFarland; Megan Johnson Shen; Kirk Harris; John Mandeli; Amy Tiersten; Jimmie Holland; Daniel C McFarland; Megan Johnson Shen; Kirk Harris; John Mandeli; Amy Tiersten; Jimmie Holland
Journal:  J Oncol Pract       Date:  2016-01-19       Impact factor: 3.840

4.  Polypharmacy in Patients with Ovarian Cancer.

Authors:  Sean Oldak; Stephanie Ioannou; Priyanka Kamath; Marilyn Huang; Sophia George; Brian Slomovitz; Matthew Schlumbrecht
Journal:  Oncologist       Date:  2019-04-05

5.  Patterns and predictors of antidepressant use in ambulatory cancer patients with common solid tumors.

Authors:  Michael J Fisch; Fengmin Zhao; Judith Manola; Andrew H Miller; William F Pirl; Lynne I Wagner
Journal:  Psychooncology       Date:  2014-06-14       Impact factor: 3.894

Review 6.  Depressive Spectrum Disorders in Cancer: Diagnostic Issues and Intervention. A Critical Review.

Authors:  Rosangela Caruso; Maria GiuliaNanni; Michelle B Riba; Silvana Sabato; Luigi Grassi
Journal:  Curr Psychiatry Rep       Date:  2017-06       Impact factor: 5.285

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.